2017
DOI: 10.1002/lt.24684
|View full text |Cite
|
Sign up to set email alerts
|

Disability in patients with end‐stage liver disease: Results from the functional assessment in liver transplantation study

Abstract: Cirrhosis leads to sarcopenia and functional decline that can severely impact one’s ability to function at home and in society. Self-reported disability scales to quantify disability – Activities of Daily Living (ADL) and Instrumental ADL (IADL) – are validated to predict mortality in older adults. To evaluate disability in liver transplant (LT) candidates and quantify its impact on outcomes, consecutive outpatients ≥18y listed for LT with laboratory Model for End-stage Liver Disease (MELD) score ≥12 at a sing… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
27
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 35 publications
(28 citation statements)
references
References 32 publications
1
27
0
Order By: Relevance
“…3 While several studies have investigated frailty 1,4 or aspects of frailty (eg, cardiopulmonary fitness, 5,6 disability, 7,8 ) in the pre–liver transplant setting, these tools have characteristics that have hampered efforts to fully understand if, how, and when frailty reverses after liver transplantation. For example, tools such as the Fried Frailty Index or Activities of Daily Living scale are subjective and scored on a noncontinuous scale, making them insensitive to subtle changes over time; cardiopulmonary exercise testing is technically challenging to administer, limiting the number of patients who are able to undergo repeat posttransplant testing.…”
Section: | Introductionmentioning
confidence: 99%
“…3 While several studies have investigated frailty 1,4 or aspects of frailty (eg, cardiopulmonary fitness, 5,6 disability, 7,8 ) in the pre–liver transplant setting, these tools have characteristics that have hampered efforts to fully understand if, how, and when frailty reverses after liver transplantation. For example, tools such as the Fried Frailty Index or Activities of Daily Living scale are subjective and scored on a noncontinuous scale, making them insensitive to subtle changes over time; cardiopulmonary exercise testing is technically challenging to administer, limiting the number of patients who are able to undergo repeat posttransplant testing.…”
Section: | Introductionmentioning
confidence: 99%
“…(7,8) In patients on the transplant waitlist, impaired PS has been shown to have important adverse effects on quality of life as well as survival. (5,6,9) In patients who have received a liver transplant (LT), the impact of pretransplant PS on posttransplant survival is less well described. One commonly used PS score shown to have a strong association with mortality in nontransplanted patients with CLD is the Eastern Cooperative Oncology Group (ECOG) scale.…”
mentioning
confidence: 99%
“…Sarcopenia frequently occurs in patients with chronic liver disease (CLD) regardless of its etiology (7,8). Sarcopenia in patients with CLD is associated with a decline in their quality of life and physical activity (9). Sarcopenia is also significantly associated with hepatic fibrosis (10).…”
Section: Introductionmentioning
confidence: 99%